Insider trade

Oric Pharmaceuticals (ORIC): CFO exercised options on 14K units

Dominic Piscitelli, CFO at Oric Pharmaceuticals, reported an option exercise of 14K units.

14K
Derivative units
Traded
Oct 20, 2026
Filed
Oct 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 24, 2026Insider · 1 personInsiders: 2 sales (~$8K)
  2. Sep 28, 2026InsiderCFO sold ~$181K of ORIC shares in the open market
  3. Oct 1, 2026Insider · 1 personInsiders: 2 sales (~$87K)
  4. Oct 20, 2026InsiderCFO sold ~$189K of ORIC shares in the open market

What came next

  1. Nov 16, 2026Company filing · Form 8-K · ResultsReported its results
  2. Nov 16, 20265% stakeT. Rowe Price Associates, Inc. reported a passive stake (13G) of 4.9%
  3. Nov 16, 20265% stakeEcoR1 Capital, LLC reported a passive stake (13G) of 2.9%
  4. Nov 16, 20265% stakeVIKING GLOBAL INVESTORS LP reported a passive stake (13G) of 5.7%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Oric Pharmaceuticals

For Oric Pharmaceuticals, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ORIC page.

Other recent filings by Dominic Piscitelli, Chief Financial Officer

The full history of Dominic Piscitelli, Chief Financial Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Oric Pharmaceuticals (ORIC) insider traded, and how much?

Dominic Piscitelli, CFO at Oric Pharmaceuticals, reported an option exercise of 14K units. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Oct 20, 2026. Filed: Oct 21, 2026. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Oric Pharmaceuticals recently?

For Oric Pharmaceuticals, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the ORIC page.

Does this mean ORIC stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Oric Pharmaceuticals

Everything OQRO holds on this company is on its ORIC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data